Effects of newer oral contraceptives on the inhibition of coagulation and fibrinolysis in relation to dosage and type of steroid
- 1 July 1990
- journal article
- review article
- Published by Elsevier in American Journal of Obstetrics and Gynecology
- Vol. 163 (1) , 396-403
- https://doi.org/10.1016/0002-9378(90)90590-4
Abstract
No abstract availableKeywords
This publication has 40 references indexed in Scilit:
- Normal haemostasis and its regulationBlood Reviews, 1989
- Effects of Oral Contraceptives on Blood Coagulation. A ReviewObstetrical & Gynecological Survey, 1985
- Protein S and the Regulation of Activated Protein CSeminars in Thrombosis and Hemostasis, 1984
- Serum histidine-rich glycoprotein during pregnancy and hormone treatmentScandinavian Journal of Clinical and Laboratory Investigation, 1983
- Oral contraceptives and cardiovascular disease: some questions and answers.BMJ, 1982
- Individual levels of plasma histidine-rich glycoprotein (HRG) during the normal menstrual cycle and in women on oral contraceptives low in oestrogenScandinavian Journal of Clinical and Laboratory Investigation, 1982
- Oral Contraceptives and Cardiovascular DiseaseNew England Journal of Medicine, 1981
- ORAL CONTRACEPTIVES AND THROMBOEMBOLIC DISEASE: EFFECTS OF LOWERING ŒSTROGEN CONTENTThe Lancet, 1980
- PULMONARY EMBOLISMThe Lancet, 1961
- THE BIOLOGICAL SIGNIFICANCE OF FIBRINOLYSISThe Lancet, 1956